Effects of Telemonitoring in Quality of Life Amongst Cancer Patients

Launched by UNIVERSIDAD NACIONAL ANDRES BELLO · Oct 10, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how a smartphone app called Contigo can improve the quality of life for patients with different types of cancer. The study will compare the experience of patients using this app to those receiving standard care. Researchers want to see if the app can help with things like daily symptoms, feelings of depression, and keeping up with medical appointments.

To participate, you need to be an adult over 18 years old and have recently been diagnosed with certain types of cancer, such as breast or prostate cancer, and be waiting to start treatment. You’ll need to have a smartphone and be willing to sign a consent form to join. If you have trouble using apps because of sensory or cognitive issues, or if you are part of another similar clinical trial, you may not be eligible. If you join, you can expect support through the app to help manage your health and improve your daily life during treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (\>18 years old).
• • Recent histologically confirmed diagnosis (within the last 3 months) of bronchogenic, breast, gallbladder, gastric, colorectal, or prostate cancer in any of its forms.
• • Awaiting initiation of curative intent treatment for the disease using any modality (radiation therapy, chemotherapy, immunotherapy, etc.) at the UC-Christus Cancer Center.
• • Possession of a smartphone, regardless of its native operating system (iOS® or Android®).
• • Willingness to sign an informed consent form to participate in the study.
• Exclusion Criteria:
• • Any form of sensory impairment preventing app usage.
• • Cognitive impairment.
• • Psychiatric pathology hindering app usage.
• • Unwillingness to participate in the study.
• • Concurrent participation in another clinical trial addressing healthcare technologies.